Acura Pharmaceuticals, Inc. (ACUR) Swings to Q2 Loss of 5c/Share

Acura Pharmaceuticals, Inc. (NASDAQ: ACUR) reported Q2 EPS of ($0.05), versus $0.35 reported last year.

For earnings history and earnings-related data on Acura Pharmaceuticals, Inc. (ACUR) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Wells Fargo upgrades S&P 500 Industrials to favorable
• Wells Fargo: '2027 S7P 500 Index target of 8,600-8,800'
• SU Group reports narrowed loss as revenue falls 20% in first half